Surgery after treatment with imatinib and/or sunitinib in patients with metastasized gastrointestinal stromal tumors: is it worthwhile?
about
Sunitinib in the treatment of gastrointestinal stromal tumor: patient selection and perspectivesClinical response to sunitinib as a multitargeted tyrosine-kinase inhibitor (TKI) in solid cancers: a review of clinical trials.Preoperative imatinib treatment in patients with advanced gastrointestinal stromal tumors: patient experiences and systematic review of 563 patients.Loss of Pten promotes angiogenesis and enhanced vegfaa expression in zebrafish.Optimizing surgical and imatinib therapy for the treatment of gastrointestinal stromal tumors.What are the current outcomes of advanced gastrointestinal stromal tumors: who are the long-term survivors treated initially with imatinib?Impact of targeted neoadjuvant therapies in the treatment of solid organ tumours.Controversies in the management of gastrointestinal stromal tumors.The Role of Surgery in Metastatic Gastrointestinal Stromal Tumors.Is surgery mandatory in locally advanced gastrointestinal stromal tumors after imatinib? A case report and literature review.Effective Downsizing of a Large Oesophageal Gastrointestinal Stromal Tumour with Neoadjuvant Imatinib Enabling an Uncomplicated and without Tumour Rupture Laparoscopic-Assisted Ivor-Lewis Oesophagectomy.Giant gastric gastrointestinal stromal tumor with severe peritoneal dissemination controlled by imatinib therapy following debulking surgery: a case report.Clinicopathologic factors predicting outcomes in patients with gastrointestinal stromal tumors of the rectum and colon.Nationwide trends in the incidence and outcome of patients with gastrointestinal stromal tumour in the imatinib era.
P2860
Q28069560-E53D8468-3123-428F-A8A9-271C1CD781C7Q33633431-37168555-DEDD-4D25-8DBE-03024740F6D7Q35676187-C6FA9AC0-4C2B-4E26-9C7F-60ECB3A4CC58Q37137760-11604338-1F93-4980-BB7E-62908DD7DFC2Q37298437-4A4F3E88-3BB3-4E44-90E6-CD4B92E7D4F9Q37342226-DD0322F5-18FE-4EB2-860D-6505D510CB34Q38061098-0722EA19-0BAE-401A-9080-EDCED9994F2DQ38199797-9ECF1458-5D13-4A6D-9DEA-A853E74446D3Q38714790-7C522AE7-0CDA-4785-A3D3-60CBBD012208Q38915858-42594566-EC71-4DA0-9624-34F6287DCA9FQ40812894-E4B6466A-E438-4F4A-828B-06B012BAC866Q42323499-20570FA2-D68F-437C-8C50-FFBD7953E070Q51172130-C3AE0603-F31E-43D9-A530-CA4EAD34E883Q52583005-964B636B-4D37-4D5D-865C-F776CE6A4BF4
P2860
Surgery after treatment with imatinib and/or sunitinib in patients with metastasized gastrointestinal stromal tumors: is it worthwhile?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Surgery after treatment with i ...... omal tumors: is it worthwhile?
@ast
Surgery after treatment with i ...... omal tumors: is it worthwhile?
@en
type
label
Surgery after treatment with i ...... omal tumors: is it worthwhile?
@ast
Surgery after treatment with i ...... omal tumors: is it worthwhile?
@en
prefLabel
Surgery after treatment with i ...... omal tumors: is it worthwhile?
@ast
Surgery after treatment with i ...... omal tumors: is it worthwhile?
@en
P2093
P2860
P356
P1476
Surgery after treatment with i ...... omal tumors: is it worthwhile?
@en
P2093
Cornelis Verhoef
Frits van Coevorden
Hans Gelderblom
Henk H Hartgrink
Johannes H W de Wilt
Johannes J Bonenkamp
Ronald Tielen
Stefan Sleijfer
Winette T van der Graaf
P2860
P2888
P356
10.1186/1477-7819-10-111
P577
2012-06-15T00:00:00Z
P5875
P6179
1013284281